However, there is evidence showing that the IGF2 level is decreased in the hippocampus of AD patients and a mouse model of this disease, and ectopic expression of IGF2 in the hippocampus of transgenic aged mice reduces Aβ plaques and reverses memory deficits 593. This evidence concerns the gene IGF2 and Alzheimer disease.